P

Inventor

HOWBERT J JEFFRY

US40 patents
⚠️ This page may combine multiple inventors who share the name “HOWBERT J JEFFRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LILLY CO ELI

26 patents
US5567714AOct 22, 1996

Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y

LILLY CO ELI60 citations96
US5684033ANov 4, 1997

Non-peptide tachykinin receptor antagonists

LILLY CO ELI30 citations92
US5670499ASep 23, 1997

Non-peptide tachykinin receptor antagonists

LILLY CO ELI28 citations92
US5663192ASep 2, 1997

Heterocyclic neuropeptide Y receptor antagonists

LILLY CO ELI23 citations92
US5576337ANov 19, 1996

Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y

LILLY CO ELI23 citations92
US5504094AApr 2, 1996

Use of bengothiophenls to treat pain due to an excess of neuropeptide y

LILLY CO ELI26 citations92
US5491140AFeb 13, 1996

Naphthyl tachykinin receptor antagonists to treat physiological conditions

LILLY CO ELI29 citations92
US5354778AOct 11, 1994

Antitumor compositions and methods of treatment

LILLY CO ELI20 citations92
US5565568AOct 15, 1996

2-acylaminopropanamides as tachykinin receptor antagonists

LILLY CO ELI37 citations91
US5216026AJun 1, 1993

Antitumor compositions and methods of treatment

LILLY CO ELI10 citations74
US6727255B1Apr 27, 2004

Piperidinyl and piperazinyl tachykinin receptor antagonists

LILLY CO ELI6 citations73
US6562862B1May 13, 2003

Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y

LILLY CO ELI4 citations73
US6403577B1Jun 11, 2002

Hexamethyleneiminyl tachykinin receptor antagonists

LILLY CO ELI5 citations73
US6147115ANov 14, 2000

Antitumor compositions and methods of treatment

LILLY CO ELI14 citations73
US5567715AOct 22, 1996

Methods of treating depression by inhibiting physiological conditions associated with an excess of neuropeptide Y

LILLY CO ELI9 citations73
US5234955AAug 10, 1993

Antitumor compositions and methods of treatment

LILLY CO ELI5 citations73
US5594028AJan 14, 1997

Anti-tumor method and compounds

LILLY CO ELI5 citations72
US5565494AOct 15, 1996

Antitumor compositions and methods of treatment

LILLY CO ELI7 citations72
US5302724AApr 12, 1994

Antitumor compositions and methods of treatment

LILLY CO ELI17 citations71
US5399565AMar 21, 1995

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof

LILLY CO ELI19 citations70
US6869957B1Mar 22, 2005

Non-peptide tachykinin receptor antagonists

LILLY CO ELI6 citations62
US6175013B1Jan 16, 2001

Imidazolinyl tachykinin receptor antagonists

LILLY CO ELI3 citations62
US5545641AAug 13, 1996

Methods of inhibiting physiological conditions associated with an excess of bradykinin

LILLY CO ELI4 citations62
US5643926AJul 1, 1997

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof

LILLY CO ELI2 citations61
US5300514AApr 5, 1994

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof

LILLY CO ELI4 citations61
US5514675AMay 7, 1996

Naphthyl bradykinin receptor antagonists

LILLY CO ELI1 citations52

QIAGEN GENOMICS INC

4 patents

OPERON BIOTECHNOLOGIES INC

3 patents

HOWBERT J JEFFRY

3 patents

CELLTECH R & D INC

2 patents

RAPIGENE INC

1 patent

UCB SA

1 patent